On Invalid Date, Fortress Biotech (NASDAQ: FBIO) reported Q4 2023 earnings per share (EPS) of -$0.53, up 89% year over year. Total Fortress Biotech earnings for the quarter were -$11.29 million. In the same quarter last year, Fortress Biotech's earnings per share (EPS) was -$4.82.
As of Q2 2024, Fortress Biotech's earnings has grown year over year. Fortress Biotech's earnings in the past year totalled -$68.67 million.
What is FBIO's earnings date?
Fortress Biotech's earnings date is Invalid Date. Add FBIO to your watchlist to be reminded of FBIO's next earnings announcement.
What was FBIO's revenue last quarter?
On Invalid Date, Fortress Biotech (NASDAQ: FBIO) reported Q4 2023 revenue of $19.95 million up 21.59% year over year. In the same quarter last year, Fortress Biotech's revenue was $16.40 million.
What was FBIO's revenue growth in the past year?
As of Q2 2024, Fortress Biotech's revenue has grown 11.58% year over year. This is 137.94 percentage points lower than the US Biotechnology industry revenue growth rate of 149.51%. Fortress Biotech's revenue in the past year totalled $84.51 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.